Biotech Steps In to Save the World’s Favorite Banana from Extinction

A close-up of a banana leaf showcasing distinctive yellow and brown spots, a common sign of fungal infection and plant stress.

getty

What would happen if the world’s most consumed fruit—the banana—suddenly vanished from grocery store shelves? This is not a science fiction scenario, but a very real threat facing global agriculture. Banana plantations across Asia, South America, and beyond are falling victim to Panama disease, a devastating soil-borne fungus known as Fusarium oxysporum, for which there is currently no cure.

This is not the first time the global banana industry has faced such a crisis. Before the mid-twentieth century, the dominant commercial variety was the Gros Michel banana, famed for its sweet, aromatic flavor that inspired the artificial banana flavoring we know today. However, in the 1950s, Fusarium wilt decimated Gros Michel plantations, forcing the industry to pivot to the disease-resistant Cavendish variety that dominates our grocery stores today.

A Perfect Killer

Unfortunately, the reprieve was short-lived. Cavendish plantations soon began showing signs of Panama disease, with the first infections reported in Taiwan in 1968. By the early 2000s, the pathogen had spread to Australia and Africa, eventually reaching Latin America around 2019. This time, however, the threat came from a different, far more aggressive strain: Tropical Race 4 (TR4). While the 1950s outbreak was caused by Fusarium Race 1, the current pandemic is driven by TR4, which is significantly more virulent and resilient.

TR4 acts as a perfect killer, systematically seeking out and destroying every banana plant in its path. The disease is virtually impossible to eradicate because the fungus colonizes the plant’s internal vascular system, rendering fungicides ineffective. Furthermore, its resilient spores can persist in the soil for decades, waiting to infect new crops.

“There are very few tools available to control this pathogen,” explains Li-Jun Ma, professor of Biochemistry and Molecular Biology at UMass Amherst, who specializes in studying Fusarium pathogens. Her groundbreaking research has helped identify the key biological differences between the original Race 1 and the newer TR4 strain, offering vital clues on how to combat the current global banana pandemic.

Interestingly, TR4’s extreme virulence did not arise through gradual evolution, but rather from a deadly combination of genetic factors from different fungal strains. Because all commercial bananas are propagated clonally, they are virtually genetically identical. This lack of genetic diversity means that once TR4 successfully infects a single tree, the entire global banana population becomes highly vulnerable to this aggressive pathogen.

“It is very difficult to fight against this fungus,” notes Ma. “It is highly aggressive and spreads rapidly. The fact that bananas are grown as a monoculture means that plantations worldwide are deeply endangered.”

Ma’s research has revealed that TR4’s virulence stems from its ability to produce nitric oxide gas, which weakens the immune defenses of banana plants. This nitric oxide pathway represents a potential vulnerability that scientists can target to disrupt the fungus.

“When we knock out individual genes in the nitric oxide pathway, we observe roughly a 50% reduction in virulence,” says Ma. “However, targeting individual genes may not be as effective as disrupting the upstream transcriptional regulation that controls the entire pathway.”

One promising approach to target this transcriptional machinery is RNA interference (RNAi), a technology that leverages a natural cellular mechanism to silence specific genes. By engineering plants to produce RNA sequences that target pathogens, scientists can effectively turn crops into RNAi factories. This innovative approach is already utilized against pests like corn rootworm in SmartStax PRO® corn, and it holds immense potential for combating Fusarium wilt. Ma’s lab at UMass is actively seeking collaborations to advance and develop this technology.

Banana Resistance

Another crucial strategy is to make the banana plants themselves resistant to the disease. Tropic Biosciences is at the forefront of this effort, developing TR4-resistant bananas by combining gene editing with RNA interference. Their clever approach redirects the banana’s natural RNA-silencing machinery directly against the pathogen. Using their GEiGS® (Gene Editing-induced Gene Silencing) platform, the company introduced precise modifications to a non-coding region of the banana genome to target Fusarium, all without inserting any foreign genes.

“Bananas are unique because they are propagated asexually, and historically, there has been very little biotechnology applied to them,” says Gilad Gershon, CEO of Tropic. “At Tropic, we saw this as a major opportunity. By utilizing advanced gene editing technologies like CRISPR and GEiGS®, we can address critical challenges for banana growers in ways that traditional breeding simply cannot achieve.”

Tropic achieved a major milestone in 2025, shipping plants to establish a mother plantation last December, with commercial deployment targeted for 2027.

“Tropic is uniquely positioned to bring solutions to this crisis,” says Gershon. “We work closely with the industry, and there is immense excitement about the progress we are making.”

Another key player is Elo Life Systems, which was spun off from Precision BioSciences in 2021 to launch a banana program in partnership with Dole. Elo’s strategy involves identifying natural disease-resistance mechanisms from diverse banana populations and engineering them into the Cavendish variety. In April 2023, their gene-edited bananas entered field trials in Central America, marking a significant step forward in the quest for sustainable resistance.

A Case Against Monoculture

Elo’s approach highlights a fundamental issue in banana cultivation: the global supply relies on a monoculture. While there are over 1,000 distinct banana varieties, more than 99% of commercially grown bananas are nearly identical. This genetic uniformity is precisely why the Fusarium TR4 pandemic can indiscriminately devastate plantations across the globe.

“In the wild, there is immense genetic diversity,” explains Ma. “But commercial production relies heavily on a single type. Expanding genetic diversity is one of the most effective ways to make the global banana industry less vulnerable to widespread outbreaks.”

To combat this vulnerability, countries like Costa Rica—which remains TR4-free but highly alert to the threat—are evaluating alternative banana cultivars for commercial use. Meanwhile, researchers at Queensland University of Technology have successfully transferred a naturally evolved resistance gene from a wild banana relative into the Cavendish variety. This transgenic banana has shown strong resistance and was approved for commercial cultivation in Australia in 2024.

Ultimately, there may be no single silver bullet to save the banana. Preserving this beloved fruit will likely require a multi-pronged approach: expanding genetic diversity among commercial varieties, engineering direct resistance into the plants, and targeting the molecular vulnerabilities of the Fusarium fungus. With these biotechnological tools being developed in parallel, saving the banana could become one of the most significant achievements in agricultural biotechnology.

Thank you to Katia Tarasava for research and reporting on this article.

Source link